You are here: Industry Insights > monoclonal antibody

News List

Immune Pharmaceuticals Files for Chapter 11 Protection americanpharmaceuticalreview
February 20, 2019
Immune Pharmaceuticals has filed for chapter 11 bankruptcy in the Federal Bankruptcy Court in New Jersey.Despite making progress towards a bertilimumab strategic transaction....
Global Humira sales near $20bn, but expect decline in 2019 bioprocessintl
February 03, 2019
Looking to 2019, AbbVie says US sales of its bestseller monoclonal antibody Humira (adalimumab) will continue to grow but expects a $2 billion hit from biosimilar competition.
Omeros Finalizes with FDA Clinical Plan for OMS721 Approval in IgA Nephropathy americanpharmaceuticalreview
January 21, 2019
Omeros has finalized its clinical plan for OMS721 submission and approval in immunoglobulin A nephropathy (IgAN) following a recent meeting with the U.S. Food and Drug Administration (FDA).....
Ascletis Pharma to develop Alphamab’s viral diseases drug in China pharmaceutical-technology
January 16, 2019
Ascletis Pharma has signed an exclusive licensing agreement with Suzhou Alphamab to develop an investigational candidate, KN035, for the treatment of viral diseases such as hepatitis B in Greater China....
Merck gains NASH candidate from NGM Biopharmaceuticals pharmaceutical-technology
January 08, 2019
Merck has exercised the option to license an investigational product called NGM313 from NGM Biopharmaceuticals under a strategic agreement signed between the companies in 2015.....
Neurimmune’s anti-SOD1 antibody shows promise in ALS mouse studies fiercebiotech
January 02, 2019
Mutations in the gene SOD1 can cause the enzyme it encodes to fold in ways that are harmful to neurons—an abnormality that's responsible for about ....
Luye Pharma’s Shares Drop on Acquisition of Two Biological Antibodies firstwordpharma
December 25, 2018
Luye Pharma announced that it acquired the biological monoclonal antibodies, LY01011 and LY09004, from Shandong Boan Biological Technology for nearly $73 million, reported Investing.com.
WuXi Biologics Congratulates Tychan on First-in-Class Monoclonal Antibody for Yellow Fever after Record 7 Months of Development en-cphi.cn
December 13, 2018
WuXi Biologics congratulates its partner Tychan for dosing of first individual in phase 1 trial of TY
Eisai, UCL commence phase I clinical studies for anti-tau monoclonal antibody expressbpd
December 10, 2018
Eisai, UCL commence phase I clinical studies for anti-tau monoclonal antibody
Darzalex Phase 3 Study Shows Efficacy and Safety Data of Anti-CD38 Monoclonal Antibody in Patients with Newly Diagnosed Multiple Myeloma americanpharmaceuticalreview
December 06, 2018
The Janssen Pharmaceutical Companies of Johnson & Johnson announced results from the Phase 3 MAIA study demonstrating that the addition of daratumumab to....

Previous page 1 2 3 4 5 6 Next page